AstraZeneca Iressa NDA Filing Complete: Will HIV Model Fly In Oncology?
AstraZeneca plans to supplement the Iressa (ZD1839) NDA with safety data from an 11,000-patient expanded access program
AstraZeneca plans to supplement the Iressa (ZD1839) NDA with safety data from an 11,000-patient expanded access program